Pacira BioSciences, Inc. — Director's Dealing 2014

Jun 6, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pacira Pharmaceuticals, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2014-06-03

Reporting Person: Greenstreet Yvonne (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-06-03	Stock Option (Right to Buy)	$81.00	A	8000	Acquired	2024-06-03	Common Stock (8000)	Direct

Footnotes

F1: The stock option vests and becomes exercisable in twelve equal monthly installments beginning on July 3, 2014.